Appointment of Joint Broker

RNS Number : 4920T

Zotefoams PLC

06 January 2017

 

Zotefoams plc

("Zotefoams" or "the Company")

Appointment of Joint Broker

6 January 2017 - Zotefoams, a world leader in cellular materials technology, today announces the appointment of Arden Partners plc to act as its joint broker alongside Investec Bank plc, with immediate effect.

- Ends -

Enquiries:

Zotefoams plc	[phone]
David Stirling, Group CEO
Gary McGrath, Finance Director
FTI Consulting	[phone]
Victoria Foster Mitchell / Simon Conway

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide.  Zotefoams uses its own cellular materials to manufacture T-FIT^® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell^® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).

www.zotefoams.com

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell^® is a registered trademark of Trexel Inc.

 

END

 

 

APPBAMTTMBTMTFR